Effect of L-carnitine on the synthesis of nitric oxide in RAW 264·7 murine macrophage cell line

Cell Biochemistry and Function

Volumn 29, Issue 8, 2011, Pages 679-685

  Koc, A ^a   Ozkan, T ^a   Karabay, A Z ^a   Sunguroglu, A ^a   Aktan, F ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Inducible nitric oxide synthase (iNOS); L carnitine; Lipopolysaccharide (LPS); Nuclear factor B (NF B); RAW 264 7

Indexed keywords

CARNITINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRITE;

ANIMAL CELL; ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SCREENING; INHIBITION KINETICS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CARNITINE; CELL LINE; GENE EXPRESSION; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

MURINAE;

EID: 83055186665     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1807     Document Type: Article

References (35)

1. Irat AM, Aktan F, Ozansoy G. Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivitiy of streptozotocin-diabetic aorta. J Pharm Pharmacol 2003; 10: 1389-1395.
2. Rebouche CJ. Carnitine function and requirements during the life cycle. FASEB J 1992; 6: 3379-3386.
3. Lu J, Head E, Kratsune H, Cotman CW, Ames BN. Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity and oxidative stress biomarkers in the brain of old rats. Ann New York Acad Sci 2004; 1033: 1-15.
4. Mamoulakis D, Galanakis E, Dionyssopoulou E, Evangeliou A, Sbyrakis S. Carnitine deficiency in childeren and adolecents with type 1 diabetes. J Diabetes Complicat 2004; 18: 271-274.
5. Flippo C, Taylor M, Mestroni L, Botto L, Longo N. Cardiomyopathy and carnitine deficiency. Mol Genet Metab 2008; 94(2): 162-166.
6. Ramalakshmi S, Baben M, Ashok BS, Jayanthi V, Lesile N, Abraham G. Association of carnitine deficiency in indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoetin use, residual rena function and diabetes mellitus. Perit Dial Int 2007; 27(Suppl 2): 235-238.
7. Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garet Q. Role of carnitine in disease. Nutr Metab (Lond) 2010; 7: 30.
8. Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 471-479.
9. Palmer RM, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153: 1251-1256.
10. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls and controls. Cell 1994; 78: 915-918.
11. Kanwar JR, Rupinder K, Burrow H, Baratchi S. Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders. Curr Med Chem 2009; 16: 2373-2394.
12. Ma JS, Kim WJ, Kim JJ, et al. Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kB and IFN-beta/STAT1 pathways in RAW 264.7 cells. Nitric Oxide 2010; 23: 214-219.
13. Goldring CEP, Reveneau S, Algarte M, Jennin JF. In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of the numerous sites including Oct and NF-IL6. Nucleic Acid Res 1996; 24: 1682-1687.
14. Martin E, Nathan C, Xie QW. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994; 180: 977-984.
15. Xie Q, Kashiwabara Y, Nathan YC. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-4708.
16. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260.
17. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci 2004; 75: 639-653.
18. Martin de R, Hoeth M, Hofer-Warbinek R, Schmid J. The Transcription Factor NF-kB and the Regulation of Vascular Cell Function. Arterioscler Thromb Vasc Biol 2000; 20: e83-e88.
19. Mossman BT. In vitro approaches for determining mechanisms of toxicity and carcinogenecity by asbestos in the gastrointestinal and respiratory tracts. Environ Health Perspect 1983; 53: 155-161.
20. Griess P. Bemerkungen zu der abhandlung der HH Weselsky und Benedikt. Ueber einige azoverbindungen. Chem Ber 1879; 12: 426-428.
21. de las Heras B, Hortelano S, Giron N, Bermejo J, Rodriguez B, Bosca L. Kaurene diterpenes protect against apoptosis and inhibition of phagocytosis in activated macrophages. B J Pharmacol 2007; 152: 249-255.
22. Bradford MA. Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal Biochem 1976; 72: 248-254.
23. Gulcin I. Antioxidant and antiradical activities of l-carnitine. Life Sci 2006; 78: 803-811.
24. Famularo G, Simone C, Trinchieri V, Mosca L. Carnitines and its congeners. A metabolic pathway to the regulation of immune response and inflammation. Ann N Y Acad Sci 2004; 1033: 132-138.
25. Bayraktar N, Pasaoglu H, Pasaoglu A, Kaymaz M, Biberoǧlu G, Kulaksizoǧlu S. The Relationship between Carnitine levels and Lipid Peroxidation in Glial Brain tumors. Turk J Med Sci 2008; 38: 293-299.
26. Feller AG, Rudman D. Role of carnitine in human nutrition. J Nutr 1988; 118: 541-547.
27. Stuehr DJ, Marletta MA. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res 1987; 47: 5590-5594.
28. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors:possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 253-264.
29. Pelletier JP, Jovanovic D, Fernandes JC, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998; 411: 275-1286.
30. Lohinai Z, Benedek P, Feher E, et al. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced peridontitis in the rat. Br J Pharmacol 1998; 123: 353-360.
31. Shin T, Tanuma N, Kim S, et al. An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rat. J Neuroimmunol 1998; 92: 133-138.
32. Hua LL, Liu JS, Brosnan CF, Lee SC. Selective inhibition of human glial inducible nitric oxide synthase by interferon beta: implications for multiple sclerosis. Ann Neurol 1998; 43: 384-387.
33. Levy B, Valtier M, De Chillou C, Bollaert PE, Cane D, Mallie JP. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats. Shock 1999; 11: 98-103.
34. Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 2010; 23: 75-93.
35. Hauton D, Evans R. Utilisation of fatty acid and triacylglycerol by rat macrophages: the effect of endotoxin. Cell Physiol Biochem 2002; 12: 293-304.